WJET Erie on MSN1d
Drugmaker to settle nearly 80,000 Zantac lawsuits for up to $2.2 billionUK-based pharmaceutical giant GSK, or GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 state-level ...
In a report released on October 10, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), ...
The settlement, announced on Wednesday, resolves 93% of all Zantac cases in state courts against GlaxoSmithKline.
GlaxoSmithKline Pharma, celebrating 100 years in India, is shifting to a specialty-focused model by entering the oncology ...
In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a ...
Pioneering Discussions at IISLD 2024: Advancing Treatment for PBC and Alpha-1 Antitrypsin Deficiency
This year's International Symposium on Liver Diseases (IISLD) 2024, held in the San Diego Convention Center, includes two key ...
GlaxoSmithKline (GSK) saw its shares jump more than 6% after the pharmaceutical giant announced a settlement of up to $2.2 ...
Hosted on MSN1d
GSK Shares Soar on $2.2B Zantac Lawsuit SettlementShares of the UK-based pharma giant GlaxoSmithKline PLC ($GB:GSK) soared over 6% after the company announced a settlement of ...
Cerebras is playing in a huge market with insatiable investor demand, but its IPO prospectus is littered with red flags that ...
New phase 3 results should reopen discussion about the off-label use of COMT inhibitors in early Parkinson's disease, experts ...
AstraZeneca and GlaxoSmithKline produce some of the most widely used inhalers in the United States, including Symbicort and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback